Skip to main content
. 2021 May 25;22(6):162–171. doi: 10.1002/acm2.13268

Table 1.

Main lymph nodes (LNs) characteristics of the patients included in this study.

Patient no. No. of LNs involved GTV of each LN (cc) PTV of each LN (cc) Combined PTV (cc) Treatment site/LNs
I 2 1.46, 4.88 8.0, 16.71 24.71 Abdominal LNs
II 2 3.01, 1.67 14.02, 7.59 21.61 Periaotic LN
III 2 0.71, 0.25 4.85, 2.11 6.96 Abdominal LNs
IV 2 2.96, 2.13 23.31, 16.19 39.50 Iliac chain LNs
V 2 0.13, 0.41 1.68, 3.89 5.57 Para aortic LNs
VI 2 3.28, 1.60 13.47, 7.53 21.00 Iliac chain LNs
VII 2 3.07, 0.48 15.23, 3.09, 18.32 Para aortic LNs
VIII 3 0.82, 0.23, 0.38 7.03, 2.64, 3.38 13.05 Para aortic + Lt common iliac LNs